Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Medicina Clinica|March 11, 2006
[Neoadjuvant therapy for operable breast-cancer]Amelia Insa, Isabel Chirivella, Ana Lluch
Archivos Espanoles De Urologia|August 20, 2008
[Coexistence of two germinal cell tumors, seminomatous and nonseminomatous, with an uncommon clinical presentation]Pilar Soriano Sarrió, Isabel Chirivella, Samuel Navarro Fos
Sexual Medicine Reviews|May 14, 2023
Prophylactic mastectomy and bilateral salpingo-oophorectomy in patients with breast cancer: a systematic review of postsurgical sexual function and menopausal hormone therapy symptom mitigationOrly Morgan, Rocio Belda, Julie Schnur, et al.
Familial Cancer|November 3, 2012
The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish familiesSarai Palanca, Inmaculada de Juan, Gema Perez-Simó, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 3, 2023
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)Ana Beatriz Sánchez-Heras, Teresa Ramon Y Cajal, Marta Pineda, et al.
Critical Reviews in Oncology/Hematology|August 30, 2021
Fertility and breast cancer: A literature review of counseling, preservation options and outcomesSantiago Moragón, Raimondo Di Liello, Begoña Bermejo, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinomaJoan Maurel, Andrés Cervantes, Carlos Conill, et al.
Breast Cancer Research and Treatment|May 9, 2008
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patientsIsabel Chirivella, Begoña Bermejo, Amelia Insa, et al.
Breast Cancer Research and Treatment|July 4, 2009
Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimensJosé Alejandro Pérez-Fidalgo, Susana Roselló, Elisa García-Garré, et al.
Journal of Personalized Medicine|July 2, 2021
Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish FamiliesMaria Fonfria, Inmaculada de Juan Jiménez, Isabel Tena, et al.
Pageof 7